Self-reported lower respiratory tract infections and development of islet autoimmunity in children with the type 1 diabetes high-risk HLA genotype: The MIDIA study

Diabetes/Metabolism Research and Reviews

Volumn 27, Issue 8, 2011, Pages 834-837

  Rasmussen, Trond ^a   Witsø, Elisabet ^a   Tapia, German ^a   Stene, Lars C ^a   Rønningen, Kjersti S ^b  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Autoimmunity; Cohort study; High risk children; RSV; Type 1 diabetes; Wheezing

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; IA2 ANTIBODY; INSULIN ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNITY; BRONCHIOLITIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK PATIENT; HUMAN; IMMUNOASSAY; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; LONGITUDINAL STUDY; LOWER RESPIRATORY TRACT INFECTION; MALE; NEWBORN; NORWAY; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT;

AUTOIMMUNITY; BRONCHITIS; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; GENOTYPE; GLUTAMATE DECARBOXYLASE; HLA-DQ ANTIGENS; HLA-DR3 ANTIGEN; HLA-DR4 ANTIGEN; HUMANS; INFANT; INFANT, NEWBORN; INSULIN; ISLETS OF LANGERHANS; LONGITUDINAL STUDIES; NORWAY; PNEUMONIA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY TRACT INFECTIONS; RISK; SELF REPORT;

EID: 80855138430     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1258     Document Type: Article

References (12)

1. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G, EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009; 373(9680): 2027-2033.
2. Strøm H, Engeland A, Eriksen E, Sakshaug S, Rønning M. How many and who are receiving medication for diabetes mellitus? Tidsskr Nor Laegeforen 2006; 126(6): 768-770.
3. Stene LC, Witsø E, Torjesen PA, et al. Islet autoantibody development during follow-up of high-risk children from the general Norwegian population from three months of age: design and early results from the MIDIA study. J Autoimmun 2007; 29(1): 44-51.
4. Stein RT. Long-term airway morbidity following viral LRTI in early infancy: recurrent wheezing or asthma?. Paediatr Respir Rev 2009; 10(Suppl. 1): 29-31.
5. Thorburn K, Harigopal S, Reddy V, Taylor N, van Saene HK. High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis. Thorax 2006; 61(7): 611-615.
6. Bingley PJ, Bonifacio E, Mueller PW. Diabetes Antibody Standardization Program: first assay proficiency evaluation. Diabetes 2003; 52(5): 1128-1136.
7. Forster J, Ihorst G, Rieger CH, et al. Prospective population-based study of viral lower respiratory tract infections in children under 3 years of age (the PRI.DE study). Eur J Pediatr 2004; 163(12): 709-716.
8. Puig C, Sunyer J, Garcia-Algar O, et al. Incidence and risk factors of lower respiratory tract illnesses during infancy in a Mediterranean birth cohort. Acta Paediatr 2008; 97(10): 1406-1411.
9. Gamble DR, Kinsley ML, FitzGerald MG, Bolton R, Taylor KW. Viral antibodies in diabetes mellitus. Br Med J 1969; 3(5671): 627-630.
10. Gamble DR. Relation of antecedent illness to development of diabetes in children. Br Med J 1980; 281(6233): 99-101.
11. Di Carlo P, Romano A, Salsa L, et al. Epidemiological assessment of Respiratory Syncytial Virus infection in hospitalized infants, during the season 2005-2006 in Palermo, Italy. Ital J Pediatr 2009; 35(1): 11.
12. Goetghebuer T, Kwiatkowski D, Thomson A, Hull J. Familial susceptibility to severe respiratory infection in early life. Pediatr Pulmonol 2004; 38(4): 321-328.